warfarin and Adenocarcinoma-of-Lung

warfarin has been researched along with Adenocarcinoma-of-Lung* in 1 studies

Other Studies

1 other study(ies) available for warfarin and Adenocarcinoma-of-Lung

ArticleYear
Warfarin-Resistant Deep Vein Thrombosis during the Treatment of Acute Ischemic Stroke in Lung Adenocarcinoma.
    Journal of stroke and cerebrovascular diseases : the official journal of National Stroke Association, 2016, Volume: 25, Issue:9

    A 66-year-old man with acute ischemic stroke in the setting of lung adenocarcinoma developed acute-onset deep vein thrombosis (DVT) of the lower limbs after changing to warfarin from a heparin combination. The diagnosis of warfarin-resistant DVT was established based on the laboratory data and clinical evaluation. Heparin administration resulted in good control of thrombin regulation. Cancer patients are at high risk of venous thromboembolism, and the combination of these 2 conditions is known as Trousseau's syndrome.. Our report suggests that heparin administration may provide good control of thromboembolic events, although there is no established medical treatment to extend the survival of patients with Trousseau's syndrome.

    Topics: Adenocarcinoma; Adenocarcinoma of Lung; Aged; Anticoagulants; Diffusion Magnetic Resonance Imaging; Humans; Lung Neoplasms; Male; Stroke; Tomography Scanners, X-Ray Computed; Venous Thrombosis; Warfarin

2016